 WON-SALEM, N.C., March 01, 2022 GLOBE NEWSWIRE -- ProKidney LP ProKidney, a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease CKD and prevention of end-stage renal disease ESRD and need for dialysis, today announced that Joseph Stavas, MD, MPH, Senior Vice President of Clinical Development, will present data on the Companys lead product candiate, Renal Autologous Cell Therapy REACT at the 4th Annual CKD Summit, being held March 1-3, 2022 in Boston, MA. 